QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia
Recruiting · NCT06456528 · Registry updated 2026-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia | Cancer Treatment-Induced Thrombocytopenia | Recruiting | Phase 2 / Phase 3 | 2026-09-09 | NCT06456528 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Qilu Pharmaceutical Co., Ltd. | 126 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin First Hospital | Harbin | China | 3 |
| Nanjing Tianyinshan Hospital | Nanjing | China | 4 |